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ttp://dx.doi.org/10.1016/j.ajpath.2013.07.008IL-10 production during intracellular bacterial infections is generally thought to be detrimental because
of its role in suppressing protective T-helper cell 1 (Th1) responses. Francisella tularensis is a facultative
intracellular bacterium that activates both Th1 and Th17 protective immune responses. Herein, we
report that IL-10edeﬁcient mice (Il10/), despite having increased Th1 and Th17 responses, exhibit
increased mortality after pulmonary infection with F. tularensis live vaccine strain. We demonstrate that
the increased mortality observed in Il10/-infected mice is due to exacerbated IL-17 production that
causes increased neutrophil recruitment and associated lung pathology. Thus, although IL-17 is
required for protective immunity against pulmonary infection with F. tularensis live vaccine strain, its
production is tightly regulated by IL-10 to generate efﬁcient induction of protective immunity without
mediating pathology. These data suggest a critical role for IL-10 in maintaining the delicate balance
between host immunity and pathology during pulmonary infection with F. tularensis live vaccine strain.
(Am J Pathol 2013, 183: 1397e1404; http://dx.doi.org/10.1016/j.ajpath.2013.07.008)Supported by NIH grants HL105427 (S.A.K.), T32 AI065380-08
(S.R.S.), and U19 AI91036 (J.R.-M.); Children’s Hospital of Pittsburgh
Research Advisory Committee, Children’s Hospital of Pittsburgh, Univer-
sity of Pittsburgh Medical Center Health System grants (L.M. and S.R.S.);
and Department of Medicine, University of Rochester, funds (J.R.-M.).Francisella tularensis, a facultative intracellular bacterium,
because of its infectious nature and the severe disease
caused by low doses of airborne bacteria, has been classiﬁed
as a category A select bioterrorism agent.1 Infection in
humans is caused by two main subspecies, F. tularensis
(type A) and Francisella holarctica (type B).2 An
F. tularensis live vaccine strain (LVS) has been developed
from the F. tularensis B strain as an experimental vaccine,
but is not licensed for use in humans.1 F. tularensis LVS has
been used as a representative attenuated model to address
the immune requirements for protection against Francisella.
By using this model, the importance of IL-12 in driving
interferon g (IFN-g) and T-helper cell 1 (Th1) responses in
immunity to F. tularensis LVS infection is well
described.3e5 In contrast, IL-17 is generally thought to play
a role in protection against extracellular, but not intracel-
lular, pathogens.6 However, we and others recently identi-
ﬁed a protective role for IL-17 in the induction of cellular
immunity to F. tularensis LVS pulmonary infection,7e9 bystigative Pathology.
.driving the production of IFN-g through IL-12 induction.7
IL-17 is a proinﬂammatory cytokine also known to induce
chemokines, such as keratinocyte chemoattractant, macro-
phage inﬂammatory protein 2 (MIP-2), and granulocyte
colony-stimulating factor (G-CSF), to mediate granulopoi-
esis, neutrophil recruitment, and inﬂammation.6 Accord-
ingly, the absence of IL-17 during F. tularensis LVS
pulmonary infection also results in decreased induction of
G-CSF and MIP-2, as well as decreased accumulation of
neutrophils and lung inﬂammation.7 Neutrophil depletion
alone does not affect bacterial control after pulmonary
infection with F. tularensis LVS,10 suggesting that the role
for IL-17 in driving Th1 responses, and not neutrophil
Slight et alrecruitment, was the primary immune mechanism mediating
protection in this model.7 These data together suggest that
both IL-17 and IFN-g are required for generating protective
immunity to pulmonary F. tularensis LVS infection.
IL-10 is an anti-inﬂammatory cytokine best studied for its
inhibitory effects on IL-12 production and down-regulation
of Th1 responses.11 Accordingly, IL-10edeﬁcient mice
show enhanced protection in models of intracellular bacterial
infections, such as Mycobacterium tuberculosis12 and Lis-
teria monocytogenes.13 In addition, in a cutaneous model of
F. tularensis LVS infection, IL-10edeﬁcient mice exhibit
increased protection, and this was reversed when IL-17 was
depleted.14 In contrast to these published studies, in the
current study, we report that after pulmonary infection with
F. tularensis LVS, mice deﬁcient in IL-10 (Il10/) exhibit
increased mortality. We clearly demonstrate that the
increased mortality in the Il10/-infected mice is not asso-
ciated with loss of protective immunity, because bacterial
burden between wild-type and Il10/ mice is similar, but is
caused by exacerbated inﬂammation and increased lung
pathology. We demonstrate that the exacerbated inﬂamma-
tion observed in Il10/-infected mice is the result of unre-
strained IL-17 production and IL-17edependent recruitment
of neutrophils and resulting lung pathology. These data
together suggest that, although IL-17 is required for protec-
tive immunity against pulmonary infection with F. tularensis
LVS,7,9 IL-17 production is tightly regulated by anti-
inﬂammatory cytokines, such as IL-10. Our studies high-
light how inﬂammatory cytokines, such as IL-17, can be
beneﬁcial for host protection, but when produced unre-
strained, can mediate host pathology.
Materials and Methods
Animals and Experimental Infection
C57BL/6 (B6) and Il10/ mice were purchased from The
Jackson Laboratory (Bar Harbor, ME). Il17/ mice15 were
crossed to the Il10/ mice, and Il17//Il-10/ double-
deﬁcient mice were generated in house on the B6 back-
ground and were used in accordance with University of
Pittsburgh Institutional Animal Care and Use Committee
guidelines. F. tularensis LVS (BEI Resources, Manassas,
VA) were grown inMueller-Hinton (MH) broth or agar.5 For
pulmonary infections, mice were infected with 1000 colony-
forming units (CFUs) of F. tularensis LVS. On day 6 after
infection, serial dilutions of the homogenized infected lungs
were plated on MH agar plates and lung CFUs were deter-
mined. In some experiments, survival was monitored in
infected B6- and gene-deﬁcient mice. For depletion of
neutrophils, mice were treated with 300 mg of Gr1-depleting
antibody (clone IA8; BioXCell, West Lebanon, NH) or
isotype control antibody (BioXCell) every 48 hours, as
previously described.16 In some experiments, single-cell lung
suspensions were prepared, as previously described, and used
for ﬂow cytometric analyses.71398Histological and Immunoﬂuorescence Data
Lungs from mice were inﬂated with 10% neutral-buffered
formalin and embedded in parafﬁn. Lung sectionswere stained
with H&E stain (Colorado Histo-Prep, Fort Collins, CO) and
processed routinely for light microscopy. Slides were scored
by one of the authors (T.D.O.), who was blinded to the sample
groups. Brieﬂy, every ﬁeld in the entire lung was observed
with a light microscope and scored for inﬂammation, as
previously described.17 Scoring was based on the percentage
of alveolar tissue with inﬂammation, according to the
following scale: 0, no inﬂammation; 1, 1% to <25%; 2, 25%
to <50%; 3, 50% to <75%; and 4, 75% to 100% inﬂamma-
tion. For immunoﬂuorescence, parafﬁn was removed from the
formalin-ﬁxed lung sections, as previously described,7 and
samples were probed with biotinylated rat, anti-mouse GR1
(Rat AL-21; BD Pharmingen). Slow-fade gold antifade with
DAPI (Molecular Probes, Grand Island, NY) was used to
counterstain tissues and detect nuclei. Images were obtained
with a Zeiss Axioplan 2 microscope (Carl Zeiss Microscopy,
Jena, Germany) and were recorded with a Zeiss AxioCam
digital camera (Carl Zeiss Microscopy).
Determination of Protein Amounts
IL-10, IL-12, and IL-23 protein levels were measured using
a Mouse Duoset enzyme-linked immunosorbent assay
(ELISA; R&D Systems, Minneapolis, MN). Other cytokine
and chemokine protein levels were determined with a mouse
Luminex assay (Linco/Millipore, Billerica, MA). Myelo-
peroxidase (MPO) chlorination and peroxidase activity were
determined in lung homogenates using the MPO activity
assay kit (Invitrogen, Grand Island, NY).
Flow Cytometry
Single-cell suspensions were stained with ﬂuorochrome-
labeled antibodies speciﬁc for CD11c (HL3), Gr1 (RB6-
8C5), CD11b (M1/70), CD3 (145-2C11), CD4 (RM4-5),
NK1.1 (PK136), gd T cells (GL3), IFN-g (XMG1.2), IL-10
(JES5-16E3), and IL-17 (TC11-18H10) or relevant isotype
control antibodies. For analysis of intracellular cytokines, cells
were stimulated with 50 ng/mL phorbol myristate acetate; 750
ng/mL ionomycin (Sigma Aldrich, St. Louis, MO) in the
presence of Golgistop (BD Pharmingen, San Jose, CA) was
surface stained, permeabilized with Cytoﬁx-Cytoperm solu-
tion (BD Pharmingen), and stained for relevant cytokines.
Cells were collected in a Becton Dickinson FACS Aria ﬂow
cytometer with FACS Diva software version 6.1.2. Cells were
gated based on their forward-by-side scatter characteristics,
and the frequency of speciﬁc cell types was calculated using
FlowJo version 7.6.5 (Tree Star Inc., San Carlos, CA).
CD11cþ cells with low autoﬂuorescence were designated as
lung dendritic cells (DCs), and CD11cþ cells with high
autoﬂuorescence were designated as lung macrophages, as
previously described.16,18,19ajp.amjpathol.org - The American Journal of Pathology
Figure 1 IL-10 is induced after infection with F. tularensis live vaccine strain (LVS) infection and restrains Th1 and Th17 responses. A: B6 bone marrow
dendritic cells (BMDCs) were left uninfected (UN) or infected with F. tularensis LVS (multiplicity of infection, 1:100), and IL-10, IL-12, and IL-23 levels were
determined in 48-hour culture supernatants by ELISA. B: B6 mice were infected with 1000 CFUs F. tularensis LVS intratracheally and lung homogenates from
0, 4, and 6 days after infection were assayed for IL-12 and IL-10 levels by ELISA. C: Lung suspensions from uninfected and infected mice were assayed for
IL-10 production in CD11cþ DCs and macrophages (Macs) by intracellular staining and ﬂow cytometry, and the number of IL-10-producing cells was
calculated. D and E: B6 BMDCS were left untreated (UN), stimulated with F. tularensis LVS, and isotype control antibody (LVS þ Iso) or with 10 mg/mL
antieIL-10 antibody (LVS þ a-IL-10) for 24 hours, after which OT-II T-cell receptor Tg CD4þ T cells were added to the wells, along with 5 mmol/L
ovalbumin323-339 peptide. After 6 days in culture, supernatants were assayed for IFN-g (D) or IL-17 (E) production. The data points represent the means 
SD of values from three to four samples (A, D, and E) or four to six mice (B and C). *P  0.05, **P  0.005, and ***P  0.0005. One experiment is
representative of two or more.
IL-17 Mediates Pathology during TularemiaGeneration and Stimulation of BMDCs
Bone marrow dendritic cells (BMDCs) were generated
from bone marrow.7 On day 7, nonadherent cells were
infected with F. tularensis LVS (multiplicity of infection,
1:100) alone or in combination with 10 mg/mL aIL-10
antibody (clone: JES5-2A5; BioXCell) or isotype control
antibody (Rat IgG1; BioXCell) in antibiotic-free Dulbec-
co’s modiﬁed Eagle’s medium for 48 hours. Naïve CD4þ T
cells were isolated from OT-II T-cell receptor ab Tg mice
using magnetic CD4þ beads (GK1.5) (Miltenyi Biotec,
Auburn, CA) and were cultured with 1  106 cells F.
tularensis LVS-stimulated or unstimulated BMDCs/mL,
with 5 mmol/L ovalbumin323-339 peptide for 6 days, as
previously described.7 Culture supernatants were then
analyzed by ELISA.Statistical Analysis
Differences between the means of two experimental groups
were analyzed using the two-tailed Student’s t-test; a one-
way analysis of variance test was used when more than
two groups were analyzed. The log-rank test was used for
statistical analyses for the survival studies. Differences were
considered signiﬁcant when P  0.05.The American Journal of Pathology - ajp.amjpathol.orgResults
F. tularensis LVSeInduced IL-10 Production Limits
Both Th1 and Th17 Responses
During intracellular bacterial infections, IL-10 expression is
detrimental,12,13 because IL-10edeﬁcient mice (Il10/)
show enhanced protection and decreased bacterial burdens.
However, the functional role for IL-10 in the context of F.
tularensis LVS infection has not been completely explored.
We found that BMDCs from B6 mice produced IL-10 and
other polarizing cytokines, such as IL-12 and IL-23, on
infection with F. tularensis LVS (Figure 1A). In addition, IL-
10 protein was induced early in the lung, whereas IL-12 levels
were induced at a later time point after pulmonaryF. tularensis
LVS infection (Figure 1B). Lung IL-23 levels were lower than
detectable levels (data not shown). LungCD11cþDCs, but not
lung macrophages, were one of the primary sources of IL-10
and accumulated at early time points after pulmonary infec-
tion (Figure 1C). Both Th1 and Th17 responses are required
for protective immunity against F. tularensis LVS pulmo-
nary infection.5,7 To address the role of F. tularensis
LVS-induced IL-10 on Th1 and Th17 responses, we treated
F. tularensis LVS-infected B6 BMDCs with IL-10e
neutralizing antibody in a DC:T-cell co-culture system and
found that IL-10 neutralization resulted in enhanced IFN-g1399
Figure 2 A: Dysregulated IL-17 production in
Il10/ mice mediates increased mortality and lung
pathological characteristics after pulmonary
F. tularensis LVS infection. B6, Il10/, and
Il10//Il17/ mice were infected with 1000 CFUs
F. tularensis LVS intratracheally, and the mice that
survived were monitored over time. Statistical
signiﬁcancewas determined by log-rank test between
survival in B6-infected and Il10/ mice, and
between B6-infected and Il10//Il17/-infected
mice. B: On days 3 and 6 after infection, lung
bacterial burden was determined by plating on MH
agar plates. C and D: Day 6, formalin-ﬁxed, parafﬁn-
embedded (FFPE) serial lung sections were stained
with H&E(C), and sections were scored for percentage
of inﬂammation, as described in Materials and
Methods (D). E and F: Lung homogenates from
infected B6 and gene-deﬁcient mice were assayed for
IL-17 (E) and IFN-g (F) levels. The data points
represent the means  SD of values from 6 to 10
mice. *P  0.05, **P  0.005, and ***P  0.0005.
Original magniﬁcation, 10 (C). One experiment is
representative of two. UN, uninfected.
Slight et aland IL-17 production by CD4þ T cells (Figure 1, D and E,
respectively). These data suggest that IL-10, induced after
F. tularensis LVS infection, may limit both Th1 and Th17
responses.
IL-17eDependent Inﬂammation Mediates Increased
Mortality in Il10/ Mice after F. tularensis LVS
Pulmonary Infection
In vitro data suggest that IL-10 may limit both Th1 and Th17
responses, and its presence may be detrimental for protective
immunity against F. tularensis LVS infection. Unexpectedly,
when Il10/ mice were infected intratracheally with F.
tularensis LVS, they demonstrated decreased survival and
increased mortality, when compared with control B6-infected
mice (Figure 2A). Interestingly, Il10/-infected mice had
similar levels of bacterial burden in the lungs at both early and
later time points, suggesting that the decreased survival was not
associatedwith increased bacterial burden (Figure 2B).We also
found that Il10/ mice displayed heightened pathology and
severe pulmonary inﬂammation (Figure 2, C and D), suggest-
ing that Il10/-infected mice die as a consequence of
increased inﬂammation rather than loss of protective immunity.
In vitro data using DC:T-cell co-cultures suggest that IL-10
production restrains both IL-17 and IFN-g responses in
CD4þ T cells (Figure 1, D and E). Therefore, we next
addressed whether IL-10 also restrains IL-17 and IFN-g
responses in vivo, andwhether dysregulated expression of these
proinﬂammatory cytokines mediates pathology and inﬂam-
mation during pulmonary tularemia. We found that, when
compared with B6 F. tularensis LVS-infected lungs, Il10/-
infected lungs expressed signiﬁcantly higher levels of IL-17
(Figure 2E) and IFN-g protein (Figure 2F). Both gd T cells
and CD4þ T cells are major producers of IL-17 in response to
pulmonary infection with F. tularensis LVS.7,9 Accordingly,1400although numbers of CD4þ and gd T cells producing IL-17
were increased in B6-infected lungs compared with unin-
fected lungs, their numbers were further enhanced in Il10/-
infected lungs (Table 1). These data suggest that, in addition to
its known role in restraining Th1 responses,11 IL-10 also has
a role in restraining Th17 responses after pulmonary infection
with F. tularensis LVS.
The absence of IL-17 during pulmonary tularemia results in
decreased inﬂammation in the infected lung.7 Therefore, we
hypothesized that excess IL-17, rather than excess IFN-g,
caused the inﬂammation, and increased the mortality observed
in the Il10/-infected mice. To address this, we generated IL-
10/IL-17 double-deﬁcient mice (Il10//Il17/) and infected
them with F. tularensis LVS via the pulmonary route. We
found that absence of IL-17 signiﬁcantly reversed the
increased susceptibility seen in Il10/ mice (Figure 2A).
More importantly, we found that the heightened pathological
characteristics observed in the lungs of infected Il10/ mice
were also reversed in lungs from Il10//Il17/-infected
mice (Figure 2, C and D). We have recently shown that IL-17
is protective and is required to drive IL-12edriven Th1-
protective cell immunity against F. tularensis LVS.7 This
role for IL-17 is likely to overcome the inhibitory effects of IL-
10 on IL-12 production, as demonstrated by us in another
intracellular bacterial model (namely, Mycobacterium bovis
bacillus Calmette-Guerin exposure).20 In support of a role for
IL-17 in driving IFN-g responses speciﬁcally to overcome IL-
10emediated inhibition, signiﬁcantly higher levels of IFN-g
were found in lungs of both Il10/ and Il10//Il17/ mice
when compared with B6-infected lungs (Figure 2F). In addi-
tion, Il10//Il17/-infected mice showed a similar bacterial
burden to B6- and Il10/-infected mice at both early and later
time points (Figure 2B). These data together suggest that when
IL-10 is absent, IL-17 is not required for generation of Th1
responses or overall protective immunity against pulmonaryajp.amjpathol.org - The American Journal of Pathology
Table 1 IL-17 Production on F. tularensis LVS Infection
Type of cell Uninfected lungs B6-infected lungs Il10/-infected lungs
CD4þ IL-17þ T cells 1.8  104  6  103 2.4  105  9.2  104* 4.2  105  1.5  104y
gdþ IL-17þ T cells 1.2  104  6.2  103 1.7  105  7.4  104* 2.9  105  6.1  104y
B6 and Il10/ mice were left uninfected or were infected with 1000 CFUs F. tularensis LVS intratracheally. On day 6, single-cell lung suspensions were
assayed for IL-17 production by intracellular staining and ﬂow cytometry.
*P  0.005 between B6-infected and uninfected mice.
yP  0.05 between B6-infected and Il10/-infected mice.
IL-17 Mediates Pathology during TularemiaF. tularensis LVS infection. Instead, excess IL-17 mediates
pathology during pulmonary F. tularensis LVS infection.
Dysregulated IL-17 Production Mediates Neutrophil
Recruitment and Increased Susceptibility in Il10/
F. tularensis LVS-Infected Mice
The absence of IL-17 during pulmonary tularemia results in
decreased induction of G-CSF, neutrophil recruitment, and
resulting inﬂammation in the infected lung.7 Correlating
with the increased IL-17 levels in infected Il10/ mice, we
also found increased levels of G-CSF and the neutrophil-
attracting chemokine, MIP-2, in Il10/-infected lungs
(Figure 3, A and B, respectively). This also coincided with
increased accumulation of neutrophils in the severely
inﬂamed lungs of Il10/-infected mice (Figure 3C). The
activity of MPO, an enzyme that is associated with
neutrophil activation and generation of reactive oxygen
species, leading to oxidative damage,21 was also notably
enhanced in lungs of infected Il10/ mice (Figure 3D).
More importantly, increased numbers of neutrophils also
accumulated in day 6einfected lungs of Il10/ mice
(Figure 3E). In contrast, we found that absence of IL-17 in
Il10/ mice reversed the induction of G-CSF and MIP-2
(Figure 3, A and B) and reduced neutrophil accumulation
within lung sections (Figure 3C). This coincided with
reversal of inﬂammation in the lung and decreased expres-
sion of MPO and decreased neutrophil accumulation in day
6einfected lungs from Il10//Il17/ mice, compared with
Il10/ mice (Figure 3, D and E). Together, our new data
show that exacerbated IL-17 production is pathological
during pulmonary infection with F. tularensis LVS.
To further conﬁrm that the exacerbated inﬂammation
caused because of increased neutrophil recruitment was
mediating the increased mortality in Il10/ mice, we
speciﬁcally depleted Gr1þ neutrophils using a monoclonal
antibody (clone 1A8), which is known to speciﬁcally deplete
neutrophils without affecting Gr1þ monocyte populations.22
We treated F. tularensis LVS-infected Il10/ mice with
1A8 antibody or isotype control antibody every 48 hours, and
found that Il10/ mice depleted of neutrophils exhibited
decreased susceptibility (Figure 3F) and decreased lung
inﬂammation (Figure 3, G and H). These data together
demonstrate that exacerbated neutrophil recruitment and
associated inﬂammation mediate the increased mortality seen
in Il10/ F. tularensis LVS-infected mice.The American Journal of Pathology - ajp.amjpathol.orgDiscussion
Production of IL-10 is largely believed to be detrimental for
immunity against intracellular pathogens, such as M.
tuberculosis12 and L. monocytogenes.13 In addition, IL-10
also limits the protective efﬁcacy of M. bovis bacillus
Calmette-Guerin vaccination after M. tuberculosis chal-
lenge,20,23 suggesting use of antieIL-10 as a potential
adjuvant to improve Th1 responses and immunity against
intracellular pathogens. However, in pathological condi-
tions, such as chronic inﬂammatory bowel disease,24 IL-10
deﬁciency unleashes an inﬂammatory response, which
earlier was thought to be associated with enhanced CD4þ
Th1 cells,25 but was later attributed to inﬂammatory Th17
cells.26 In contrast, IL-10 deﬁciency is associated with
enhanced Th17 responses during inﬂuenza challenge, and
a cutaneous model of F. tularensis LVS infection,14 in
which it is associated with better protective outcomes.27 In
this context, the interesting and unexpected ﬁnding reported
in this study is that unrestrained IL-17, induced in response
to pulmonary F. tularensis LVS infection in Il10/ mice,
mediates neutrophil recruitment and associated pathological
characteristics. However, because IL-17 is also required to
drive IL-12 production and generate Th1 responses during
pulmonary tularemia,7 our studies together propose the new
model that IL-17 is required to drive IL-12 and Th1
responses, likely to overcome the inhibitory effects of IL-10
on IL-12 production. In contrast, in the absence of IL-10,
dysregulated and exacerbated production of IL-17 produc-
tion is pathological and mediates inﬂammation, suggesting
a critical role for IL-10 in maintaining the delicate balance
between host immunity and pathological characteristics
during pulmonary infection with F. tularensis LVS.
Our data show that IL-10 is produced early in the lung after
pulmonary F. tularensis LVS infection and that lung DCs are
one of the primary cells producing IL-10. In addition, data
show that infection of BMDCswith F. tularensis LVS induces
IL-10 production and IL-10 neutralization in DC:T-cell co-
cultures increased both IL-17 and IFN-g production in CD4þ
T cells. These data are consistent with a previous study that
also showed that BMDCs induced IL-10mRNAand protein in
response to F. tularensis LVS infection, in a toll-like receptor-
2edependent manner.28,29 In addition, in vitro studies have
demonstrated that F. tularensis LVS, cultured in MH broth,
induces more robust IL-10 production inDCs, when compared
with host-adapted bacteria cultured in brain heart infusion1401
Figure 3 A and B: Neutrophils contribute
to lung pathological characteristics and
increased mortality in Il10/ mice after F.
tularensis LVS infection. B6, Il10/, and
Il10//Il17/ mice were infected with
1000 CFUs F. tularensis LVS intratracheally,
and on day 6, lung homogenates from infected
B6 and gene-deﬁcient mice were assayed for
G-CSF (A) and MIP-2 (B) protein levels. C:
Serial sections of day 6einfected, formalin-
ﬁxed, parafﬁn-embedded (FFPE) lungs were
stained with antibodies speciﬁc to GR1. D and
E: The level of MPO activity was determined in
lung homogenates (D), and neutrophil accu-
mulation (CD11bþ GR1þ cells) in the lungs
was enumerated using ﬂow cytometry (E). The
data points represent the means  SD of
values from 6 to 10 mice. F: Il10/mice were
infected with 1000 CFUs F. tularensis LVS
intratracheally and treated with Gr1-depleting
antibody or isotype control and monitored for
survival. G and H: Statistical signiﬁcance was
by log-rank test for the survival studies. Day 6,
formalin-ﬁxed, parafﬁn-embedded (FFPE)
serial lung sections were stained with H&E (G),
and sections were scored for percentage of
inﬂammation, as described in Materials and
Methods (H). The data points represent the
means SD of values from 6 to 10 mice. *P
0.05, **P  0.005, and ***P  0.0005. One
experiment is representative of two or more.
Slight et almedia.29 However, these differences are only apparent at early
time points after infection,30 and our studies, both in vitro and
in vivo, were performed over a period of 6 days or more, by
which time the bacteria are host adapted. In addition, the
observed increased mortality of Il10/ mice after F. tular-
ensis LVS infection substantiates that in vivo IL-10 is
produced and is critical for restraining Th1 and Th17
responses after infection. Accordingly, in this study, increased
IFN-g and IL-17 levels were observed in Il10/ F. tularensis
LVS-infected lungs. A previous study has demonstrated that
Il10/ DCs secrete high levels of IL-12/IL-23 p40 when
pulsed overnight with cecal bacterial lysate.31 Thus, it is
possible that the increased expression of these Th1- and Th17-
polarizing cytokines and other molecules, such as CD86, in
Il10/ DCs31 drives the increased expression of IL-17 and
IFN-g in CD4þ T cells. This ﬁnding is consistent with other
pulmonary intracellular bacterial infection models, such as1402pulmonary infection with M. tuberculosis, in which Il10/-
infected mice demonstrated increased lung IFN-g and IL-17
levels.12 However, in contrast to our study, M. tuber-
culosiseinfected Il10/ mice demonstrated better bacterial
control and no remarkable differences in lung pathology.12
These data suggest that in some pulmonary infection
models, such as F. tularensis LVS, IL-10 plays dual roles. On
one hand, IL-10 restrains the inﬂammatory effects of IL-17
and is beneﬁcial, whereas on the other hand, IL-10 restrains
IL-12 and IFN-g responses and is detrimental to host immu-
nity. Thus, our studies further suggest that the indirect role for
IL-17 in driving IL-12 production and Th1 responses is to
overcome the inhibitory effects of IL-10 on IL-12 and Th1
responses. This hypothesis is consistent with the ﬁnding that,
although Il17/ mice are more susceptible to pulmonary
F. tularensis LVS infection and have increased lung bacterial
burden and decreased lung IFN-g levels,7 this requirement forajp.amjpathol.org - The American Journal of Pathology
IL-17 Mediates Pathology during TularemiaIL-17 in driving Th1 immunity is lost when IL-10 is absent.
Interestingly, in a cutaneous model of F. tularensis LVS
infection, increased IL-17 that is induced in the IL-
10edeﬁcient mice results in improved survival of mice.14
Thus, a recent study,14 along with data shown in this study,
demonstrate that, depending on the route of F. tularensis LVS
infection, excess IL-17 induced in response to infection can
drive either protective or pathological responses.
Recent data suggest that in vitro infection of human
monocytes with the virulent strain F. tularensis SCHU S4
induces IL-23 expression,32 and that pulmonary infection
with F. tularensis LVS induces lung Th17 cells.33 Exoge-
nous administration of IL-17 delays the time of death from
lethal intranasal F. tularensis LVS infection,9 and rescues
IFN-g production in the F. tularensis LVS-infected lung.7
In addition, IL-17 neutralization enhances bacterial burden
in previously immunized mice that were challenged with
virulent aerosolized F. tularensis SCHU S4.34 More
important, peripheral blood mononuclear cells from F.
tularensis LVS-immunized human volunteers produce IL-
17 in memory CD4þ and CD8þ T cells on stimulation
with Francisella antigens,35 suggesting that IL-17 could
serve as a good immune correlate for both primary and
secondary immunity against tularemia. In this context, it is
interesting that prostaglandin E2 is critical for induction of
IL-23 and Th17 responses,36,37 whereas it inhibits IL-12
responses through production of IL-10.38 In this context,
IL-10 restrains IL-17 production and resulting neutrophil
recruitment and inﬂammation during pulmonary infection
with F. tularensis LVS. This is clearly demonstrated in our
study because the increased inﬂammation, induction of G-
CSF and MIP-2, and neutrophil accumulation seen in Il10/-
infected lungs was completely reversed in the lungs of
Il10//Il17/-infected mice. More important, we also
provide evidence that the increased mortality seen in Il10/-
infected mice is the result of exacerbated neutrophilic
inﬂammation, because Il10/ mice depleted of neutrophils
result in decreased mortality, improved survival, and
decreased inﬂammation. Previous studies showed that deple-
tion of Gr1 cells (using the RB6-8c5 antibody) in wild-type
BALB/c mice infected with aerosolized F. tularensis LVS
did not affect bacterial burden in the lung.10 This supports our
ﬁndings that the improved survival observed in Il10/-
infected mice, which underwent neutrophil depletion, was
likely due to decreased inﬂammatory responses observed,
rather than a direct role for neutrophils, in protective immu-
nity. The absence of IL-17 in the Il10/ mice does not
completely rescue susceptibility and improve survival to
levels observed in B6-infected mice, suggesting that the
increased IFN-g responses observed in Il10/-infected lungs
may also be playing a secondary role in this model, and
should be further explored.
In summary, our data together suggest that, although IL-
17 is required for protective immunity against pulmonary
infection with F. tularensis LVS,7,9 its production is tightly
regulated by anti-inﬂammatory cytokines, such as IL-10.The American Journal of Pathology - ajp.amjpathol.orgHowever, when IL-17 production is dysregulated, it can
cause exacerbated inﬂammation, associated pathological
characteristics, and increased mortality after F. tularensis
LVS infection.
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